These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32868100)

  • 1. Platelet-Derived Products in Veterinary Medicine: A New Trend or an Effective Therapy?
    Soares CS; Babo PS; Reis RL; Carvalho PP; Gomes ME
    Trends Biotechnol; 2021 Mar; 39(3):225-243. PubMed ID: 32868100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-rich Plasma and Other Hemocomponents in Veterinary Regenerative Medicine.
    Tambella AM; Martin S; Cantalamessa A; Serri E; Attili AR
    Wounds; 2018 Nov; 30(11):329-336. PubMed ID: 30418162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of a Protocol for Obtaining Platelet Rich Plasma from blood Donors; a Tool for Tissue Regeneration Procedures.
    Gómez LA; Escobar M; Peñuela O
    Clin Lab; 2015; 61(8):973-80. PubMed ID: 26427141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-rich fibrin: a boon in regenerative endodontics.
    Rebentish PD; Umashetty G; Kaur H; Doizode T; Kaslekar M; Chowdhury S
    Minerva Stomatol; 2016 Dec; 65(6):385-392. PubMed ID: 27711028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial.
    Madurantakam P; Yoganarasimha S; Hasan FK
    J Vis Exp; 2015 Sep; (103):. PubMed ID: 26485642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
    Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T
    J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Freeze-Drying of Platelet-Rich Plasma: The Quest for Standardization.
    Andia I; Perez-Valle A; Del Amo C; Maffulli N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-rich plasma to improve the bio-functionality of biomaterials.
    Anitua E; Tejero R; Alkhraisat MH; Orive G
    BioDrugs; 2013 Apr; 27(2):97-111. PubMed ID: 23329397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-derived biomaterials and platelet growth factors in regenerative medicine.
    Burnouf T; Goubran HA; Chen TM; Ou KL; El-Ekiaby M; Radosevic M
    Blood Rev; 2013 Mar; 27(2):77-89. PubMed ID: 23434399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the molecular composition and in vitro regenerative capacity of platelet-based bioproducts and related subfractions.
    Acebes-Huerta A; Martínez-Botía P; Carbajo-Argüelles G; Fernández-Fuertes J; Muñoz-Turrillas MC; Ojea-Pérez AM; López-Vázquez A; Eble JA; Gutiérrez L
    Acta Biomater; 2024 Mar; 177():132-147. PubMed ID: 38311196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of platelet growth factors in treating wounds and soft-tissue injuries.
    Rozman P; Bolta Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2007 Dec; 16(4):156-65. PubMed ID: 18204746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approaches in utilizing platelet lysate in regenerative medicine: Are we ready for clinical use?
    Zamani M; Yaghoubi Y; Movassaghpour A; Shakouri K; Mehdizadeh A; Pishgahi A; Yousefi M
    J Cell Physiol; 2019 Aug; 234(10):17172-17186. PubMed ID: 30912141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic applications of canine platelets and their derivatives: a narrative review.
    Bharti D; Ajith Y; Sharun K; Banu SA; Kumar A; Bhardwaj A; Sidar SK; Dhaleshwari
    Top Companion Anim Med; 2024; 58():100840. PubMed ID: 37979613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous fibrin scaffolds: When platelet- and plasma-derived biomolecules meet fibrin.
    Anitua E; Nurden P; Prado R; Nurden AT; Padilla S
    Biomaterials; 2019 Feb; 192():440-460. PubMed ID: 30500725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Growth Factors, Cytokines, and Chemokines in Bone Marrow Concentrate and Platelet-Rich Plasma: A Prospective Analysis.
    Ziegler CG; Van Sloun R; Gonzalez S; Whitney KE; DePhillipo NN; Kennedy MI; Dornan GJ; Evans TA; Huard J; LaPrade RF
    Am J Sports Med; 2019 Jul; 47(9):2174-2187. PubMed ID: 31034242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet derivatives in regenerative medicine: an update.
    De Pascale MR; Sommese L; Casamassimi A; Napoli C
    Transfus Med Rev; 2015 Jan; 29(1):52-61. PubMed ID: 25544600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-rich plasma.
    Saucedo JM; Yaffe MA; Berschback JC; Hsu WK; Kalainov DM
    J Hand Surg Am; 2012 Mar; 37(3):587-9; quiz 590. PubMed ID: 22305737
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma-Rich in Growth Factor and its Clinical Application.
    Sheykhhasan M; Seifalian A
    Curr Stem Cell Res Ther; 2021; 16(6):730-744. PubMed ID: 33494683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. More than 500 million years of evolution in a fibrin-based therapeutic scaffold.
    Anitua E; Nurden P; Nurden AT; Padilla S
    Regen Med; 2020 Apr; 15(4):1493-1498. PubMed ID: 32441555
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
    Sundman EA; Cole BJ; Fortier LA
    Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.